Dec 20 (Reuters) - Anatara Lifesciences Ltd ANR.AX :
* UPDATES ON PROTOCOL FOR ITS CLINICAL TRIAL IN IRRITABLE BOWEL SYNDROME (IBS) FOR ITS GARP DIETARY SUPPLEMENT.
* MET PROJECTED MILESTONE TO FINALISE DRAFT PROTOCOL FOR HUMAN CLINICAL TRIAL FOR GASTROINTESTINAL REPROGRAMMING DIETARY SUPPLEMENT